Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory Briefs: CLIA Update; Product Reclassification; Thrombogenicity Workshop

This article was originally published in The Gray Sheet

Executive Summary

FDA provides a Clinical Laboratory Improvement Amendments administrative procedures guidance update. Absorbable lung biopsy plugs are reclassified. FDA will host a public workshop to discuss methods for thrombogenicity testing on April 14.

You may also be interested in...



Updated eCopy Guidance Clarifies FDA’s Electronic Submission Program

According to an updated guidance on FDA’s eCopy submission program, it now accepts a broader range of PDFs. The update contains expanded guidelines for industry when submitting electronic versions of applications to FDA.

FDA Says Final CLIA Waiver Guidance Eases Burdens; Industry Isn’t Satisfied

Final guidelines to companies developing point-of-care diagnostic tests for use in less sophisticated laboratories offer more leeway in clinical trial design than FDA initially proposed

Ex-Janssen India Chief To Lead PE-Controlled Bharat Serums

Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.

Topics

UsernamePublicRestriction

Register

MT032834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel